From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to changing the future of Parkinson’s.

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Japan has approved two pioneering stem-cell therapies for the treatment of Parkinson’s disease and severe heart failure, marking a major milestone in ...

TOKYO — Japan has approved ground-breaking stem-cell treatments for Parkinson's disease and severe heart failure, one of the manufacturers and media reports said on Friday, with the therapies expected ...

Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. Some forms of Parkinson's disease are characterized by an inability of cells to ...

June 26 -- WEDNESDAY, June 25 (HealthDay News) -- People taking dopamine agonists to treat Parkinson's disease are at risk for impulse-control disorders such as compulsive gambling, buying and sexual ...

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...

Prisma Health will host a free virtual seminar March 10 on treatment options for Parkinson’s disease and essential tremor, ...

A drug first developed in the 1950s for Parkinson’s disease may be an unexpected ally in the global fight against tuberculosis, according to new research from the University of British Columbia (UBC).

A new initiative is set to explore the potential of repurposing existing medications to combat the symptoms of both Alzheimer’s and Parkinson’s diseases, aiming to accelerate the discovery of novel ...

The country has approved groundbreaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said, with the therapies expected to reach patients ...

Benztropine, a drug prescribed for tremors in Parkinson’s disease, has shown promise against tuberculosis (TB) in both human cell and mouse models. The corresponding study was published in npj ...